Bradenton, FLORIDA5 Active Studies

Erectile Dysfunction Clinical Trials in Bradenton, FLORIDA

Find 5 actively recruiting erectile dysfunction clinical trials in Bradenton, FLORIDA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,312
Enrolling

Recruiting Erectile Dysfunction Studies in Bradenton

RecruitingBradenton, FLORIDANCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine....

640 participants
Pfizer
View Study Details
RecruitingBradenton, FLORIDANCT06809595

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama...

250 participants
Mind Medicine, Inc.
View Study Details
RecruitingBradenton, FLORIDANCT06425159

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label...

242 participants
Biohaven Therapeutics Ltd.
View Study Details
RecruitingBradenton, FLORIDANCT07009860

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Plac...

100 participants
Altimmune, Inc.
View Study Details
RecruitingBradenton, FLORIDANCT06465186

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic s...

80 participants
Merck Sharp & Dohme LLC
View Study Details

About Erectile Dysfunction Clinical Trials in Bradenton

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 5 erectile dysfunction clinical trials recruiting participants in Bradenton, FLORIDA. These studies are seeking a combined 1,312 participants. Research is being sponsored by Pfizer, Mind Medicine, Inc., Biohaven Therapeutics Ltd. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Bradenton — FAQ

Are there erectile dysfunction clinical trials in Bradenton?

Yes, there are 5 erectile dysfunction clinical trials currently recruiting in Bradenton, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bradenton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bradenton research site will contact you about next steps.

Are clinical trials in Bradenton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bradenton studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 5 active trials in Bradenton are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated March 2, 2026 from ClinicalTrials.gov